Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Nektar Therapeutics (NQ: NKTR)
33.40 USD  -0.63 (-1.85%)
Official Closing Price  /  Updated: 5:47 PM EDT, Jun 14, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 673,700
Open 34.12
Bid (Size) 32.01 (2)
Ask (Size) 33.80 (2)
Prev. Close 34.03
Today's Range 33.23 - 34.24
52wk Range 29.22 - 69.76
Shares Outstanding 171,402,476
Dividend Yield N/A
Performance
YTD
-2.40%
-2.40%
1 Month
+6.57%
+6.57%
3 Month
-4.38%
-4.38%
6 Month
-2.22%
-2.22%
1 Year
-42.27%
-42.27%
Top News
More News
First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology
Nektar Therapeutics (Nasdaq: NKTR) today announced the results of the first-in-human Phase 1a study evaluating single-ascending doses of NKTR-358, a first-in-class T regulatory cell stimulator in... Read More
from PR Newswire
Nektar Therapeutics to Host Webcast Conference Call with Immunology Expert for Analysts & Investors During 2019 European Congress of Rheumatology (EULAR 2019)
Nektar Therapeutics (NASDAQ:NKTR) announced today that it will webcast an analyst and investor conference call with an immunology expert and company management on Thursday, June 13, 2019 at 8:00 a.m.... Read More
from PR Newswire
More News
Read More
Nektar Therapeutics Presents Biomarker and Clinical Data from PIVOT-02 Phase 2 Study of Bempegaldesleukin with Nivolumab at 2019 ASCO Annual Meeting
from PR Newswire
Nektar Announces the Launch of Inheris Biopharma, Inc.
from PR Newswire
BioXcel Pharmaceuticals CEO On Drug Pipeline, How AI Is Changing Sector
category PFE , Vimal Mehta , Market News , and 10 more.
from Benzinga
Why Cancer-Fighting Stocks & ETFs Are Soaring
category Stocks / Equities , Pharma/Biotech , ETFs , and 1 more.
from Blogs - TalkMarkets
S&P 500 Movers: CNC, NKTR
category Stocks
from Market News Video
Why El Paso Electric, Nektar Therapeutics, and Hecla Mining Jumped Today
category HL , NKTR , EE , and 1 more.
from Motley Fool
Who Are The Winners And Losers From The Year's Biggest Cancer Meeting?
from Investor's Business Daily
Here's Why Nektar Therapeutics Is Soaring Today
category NKTR , Market News , BMY
from Motley Fool
23.6% Return Seen to Date on SmarTrend Nektar Therapeut Call (NKTR)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.